Andrew C. Orth, Chief Commercial Officer: Krystal Biotech KRYS Sell · Filed 23/06/09

Trade details

Type: Insider sale
Amount: $673,934.1
Shares · price: 5,261 sh · $128.10 a share
Held after: 7,339 sh
Stock: Krystal Biotech KRYS
Person: Andrew C. OrthChief Commercial Officer
Trade date: 23/06/09
Filed: 23/06/09
Days to filing: 0 days

Sold 41.8% of holdings

Share of holding sold: 41.8%

Krystal Biotech trades, last 26 weeks

What else happened in Krystal Biotech around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Andrew C. Orth's recent trades

Andrew C. OrthChief Commercial Officer
Sell10b5-1 planKrystal Biotech
Sell10b5-1 plan
Krystal Biotech
KRYS
$890.5K
6,906 sh
$890.5K
Filed 23/06/09
Traded 23/06/09
Andrew C. OrthChief Commercial Officer
Sell10b5-1 planKrystal Biotech
Sell10b5-1 plan
Krystal Biotech
KRYS
$43.2K
333 sh
$43.2K
Filed 23/06/09
Traded 23/06/09